Photo Gallery Home   |   ASCO Press Center

Sign In

Meetings:  


2009 ASCO Annual Meeting


  Home  

  Friday  

  Saturday  

  Sunday  

  Monday  

  Tuesday  

  Alpha List  

  General List  

  List All  

  Search  


Click to Download

Date 

Speaker(s) 

Description

05/31/2009 Newton-John, Olivia
Winer MD, Eric  
Orlando, FL - ASCO 2009 Annual Meeting
05/31/2009 Newton-John, Olivia
Gralow MD, Julie  
Orlando, FL - ASCO 2009 Annual Meeting
05/31/2009 Newton-John, Olivia
Davidson MD, Nancy  
Orlando, FL - ASCO 2009 Annual Meeting
05/31/2009 Newton-John, Olivia
Schilsky MD, Richard L.  
Orlando, FL - ASCO 2009 Annual Meeting
05/31/2009 Newton-John, Olivia   Orlando, FL - ASCO 2009 Annual Meeting
05/31/2009 Smith MD, Sonali
 
Orlando, FL - ASCO 2009 Annual Meeting: Sonali Smith, MD chairs the Personalized Cancer Care Press Conference at the American Society for Clinical Oncology Annual Meeting, Sunday May 31, 2009. 2009 Photo by © ASCO/Zach Boyden-Holmes 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 Duenas-Gonzalez MD, PhD, Alfonso
 
Orlando, FL - ASCO 2009 Annual Meeting: Alfonso Duenas-Gonzalez, MD, PhD addresses the Women's Cancers Press Conference about Abstract CRA5507 at the American Society for Clinical Oncology Annual Meeting, Sunday May 31, 2009. Photo by ASCO/Scott Morgan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 O'Shaughnessy MD, Joyce
 
Orlando, FL - ASCO 2009 Annual Meeting: J. O'Shaughnessy discusses Abstract 3 - Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial. during the Plenary at the American Society for Clinical Oncology Annual Meeting here today, Sunday May 31, 2009. Photo by © ASCO/Todd Buchanan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 Clinical Trials Participation Awards"General Views
 
Orlando, FL - ASCO 2009 Annual Meeting: Clinical Trials Participation Awardees at the American Society for Clinical Oncology Annual Meeting, Sunday May 31, 2009. Photo by © ASCO/Todd Buchanan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 O'Shaughnessy MD, Joyce
 
Orlando, FL - ASCO 2009 Annual Meeting: J. O'Shaughnessy discusses Abstract 3 - Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial. during the Plenary at the American Society for Clinical Oncology Annual Meeting, Sunday May 31, 2009. Photo by © ASCO/Todd Buchanan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 Smith MD, Sonali
 
Orlando, FL - ASCO 2009 Annual Meeting: Sonali Smith, MD chairs the Personalized Cancer Care Press Conference at the American Society for Clinical Oncology Annual Meeting here today, Sunday May 31, 2009. Photo by © ASCO/Zach Boyden-Holmes 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 Vogelstein MD, Bert
 
Orlando, FL - ASCO 2009 Annual Meeting: Bert Vogelstein, MD receives the Science of Oncology Award & Lecture at the American Society for Clinical Oncology Annual Meeting, Sunday May 31, 2009. Photo by © ASCO/Todd Buchanan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 Duenas-Gonzalez MD, PhD, Alfonso
 
Orlando, FL - ASCO 2009 Annual Meeting: Alfonso Duenas-Gonzalez, MD, PhD addresses the Women?s Cancers Press Conference about Abstract CRA5507 at the American Society for Clinical Oncology Annual Meeting here today, Sunday May 31, 2009. Photo by © ASCO/Todd Buchanan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 Rustin MD, Gordon J.
 
Orlando, FL - ASCO 2009 Annual Meeting: Gordon J Rustin, MD discusses Abstract 1 - A randomized trial in ovarian cancer (OC) of early treatment of relapse based on CA125 level alone versus delayed treatment based on conventional clinical indicators (MRC OV05/EORTC 55955 trials). during the Plenary at the American Society for Clinical Oncology Annual Meeting here today, Sunday May 31, 2009. Over 25,000 physicians, researchers and healthcare professionals from over 80 countries are attending the meeting which is being held at the Orange County Convention center and features the latest cancer research in the areas of basic and clinical science. Date: Sunday May 31, 2009 Photo by © ASCO/Todd Buchanan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 Tutt MB, ChB, PhD, Andrew
 
Orlando, FL - ASCO 2009 Annual Meeting: Andrew Tutt, MB, ChB, PhD addresses the Women?s Cancers Press Conference about Abstract CRA501 at the American Society for Clinical Oncology Annual Meeting here today, Sunday May 31, 2009. Over 25,000 physicians, researchers and healthcare professionals from over 100 countries are attending the meeting which is being held at the Orange County Convention center and features the latest cancer research in the areas of basic and clinical science. Date: Sunday May 31, 2009 Photo by © ASCO/Todd Buchanan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 Lecuru MD PhD, Fabrice
 
Orlando, FL - ASCO 2009 Annual Meeting: Fabrice Lecuru, MD, PhD addresses the Women?s Cancers Press Conference about Abstract CRA5506 at the American Society for Clinical Oncology Annual Meeting, Sunday May 31, 2009. Photo by © ASCO/Todd Buchanan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 Plenary Session crowds
 
Orlando, FL - ASCO 2009 Annual Meeting: Plenary Session crowds at the American Society for Clinical Oncology Annual Meeting, Sunday May 31, 2009. Photo by © ASCO/Todd Buchanan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 Miller MD, Vincent A.
 
Orlando, FL - ASCO 2009 Annual Meeting: Vincent A. Miller, MD addresses the audience during an oral presentation about Abstract LBA8002 at the American Society for Clinical Oncology Annual Meeting here today, Sunday May 31, 2009. Photo by ASCO/Scott Morgan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 Rustin MD, Gordon J
 
Orlando, FL - ASCO 2009 Annual Meeting: Gordon J Rustin, MD discusses Abstract 1 - A randomized trial in ovarian cancer (OC) of early treatment of relapse based on CA125 level alone versus delayed treatment based on conventional clinical indicators (MRC OV05/EORTC 55955 trials). during the Plenary at the American Society for Clinical Oncology Annual Meeting, Sunday May 31, 2009. Photo by © ASCO/Todd Buchanan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
05/31/2009 Tutt MB ChB PhD, Andrew
 
Orlando, FL - ASCO 2009 Annual Meeting: Andrew Tutt, MB, ChB, PhD addresses the Women?s Cancers Press Conference about Abstract CRA501 at the American Society for Clinical Oncology Annual Meeting, Sunday May 31, 2009. Photo by © ASCO/Todd Buchanan 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
Page  1 



2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005-2009 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.